Form 4: Apellis Pharmaceuticals VP Sells Shares to Cover Tax Withholding
SEC Form 4 Filing
James George Chopas, VP/Chief Accounting Officer of Apellis Pharmaceuticals, sold 192 shares of common stock on September 16, 2024, to cover tax withholding on restricted stock units.
Summary
- James George Chopas, VP/Chief Accounting Officer of Apellis Pharmaceuticals, sold 192 shares of common stock on September 16, 2024.
- The sale was executed at a price of $36.206 per share.
- The transaction was to cover tax withholding on restricted stock units released on September 13, 2024.
- Following the transaction, Chopas directly owns 38,141 shares of Apellis Pharmaceuticals.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing detailing a routine stock sale for tax purposes, indicating a neutral sentiment.
Industry Context
Form 4 filings are a routine part of the US stock market, providing transparency into the transactions of company insiders. This particular filing indicates a sale of shares to cover tax obligations, which is a common practice.
Stakeholder Impact
- The sale of a small number of shares by an officer is unlikely to have a significant impact on shareholders.
Key Dates
| Date | Description |
|---|---|
| 09/13/2024 | Restricted Stock Units released |
| 09/16/2024 | Date of stock sale |
| 09/17/2024 | Date of signature on the Form 4 |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.